Alnylam Pharmaceuticals | ALNY - Market Capitalization

Stock Price
330.34
Daily Change
11.49 3.60%
Monthly
2.09%
Yearly
41.81%
Q2 Forecast
309.25

Alnylam Pharmaceuticals reported $42.63B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 117.34B 2.45B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025